Replies to post #1477 on Revance Therapeutics Inc (RVNC)

[rwwine]

Thanks sir for this summary. :-)

[DewDiligence]

RVNC 4Q19 CC transcript:

https://finance.yahoo.com/news/edited-transcript-rvnc-earnings-conference-070629768.html

[DewDiligence]

Musings on RVNC’s COVID-19 update: #msg-154596190.

[DewDiligence]

RVNC 1Q20 results—3/31/20 cash=$511M:

https://investors.revance.com/news-releases/news-release-details/revance-reports-first-quarter-2020-financial-results-provides

2020 operating cash burn is expected to be at the low end of the prior guidance range of $220-230M due to one-quarter delay (to 3Q20) in the US launch of Teoxane’s dermal fillers.

MYL’s decision whether to opt in for the Botox-biosimilar program is expected by the end of May.